HTG Molecular Diagnostics, Inc. (HTGMQ)

HTG Molecular Diagnostics Revenue

HTG Molecular Diagnostics had revenue of $1.03M in the quarter ending March 31, 2023, a decrease of -12.83%. This brings the company's total for the last twelve months to $6.21M, down -28.21% year-over-year. In the year 2022, HTG Molecular Diagnostics had annual revenue of $6.37M, down -28.52%. That makes HTG Molecular Diagnostics the 39,261st largest company in the world by revenue and 5,188th in the United States.

• Revenue (ttm): 6.21M
• Revenue Growth: -28.21%
• P/S Ratio: n/a
• Revenue / Employee: 115.08K
• Employees: 54
• Market Cap: 2.00

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States 4.14M 65.0%
• Outside of The United States 2.23M 35.0%

Fiscal year ended Dec 31, 2022

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	6.37M	-2.54M	-28.52%
Dec 31, 2021	8.91M	357.96K	4.19%
Dec 31, 2020	8.55M	-10.66M	-55.48%
Dec 31, 2019	19.20M	-2.30M	-10.70%
Dec 31, 2018	21.50M	6.74M	45.69%

Data Source: S&P Global Market Intelligence Last updated: May 11, 2023

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error